Martin Held

FGen GmbH

BPL developed a screening platform employing microbeads for very fast screening of microbial clones. Based on this platform, dedicated assay technologies are developed for screening of microbial production strains for synthesis of biologics.

FGen GmbH

Martin Held

Schürbungert 41
8057 Zürich

Contact

A PHILANTHROPIC INITIATIVE OF A PRIVATE CONSORTIUM

Turning scientific innovation into entrepreneurial activity and job creation is the basis of societal and economical prosperity. In the very early stages, startups bear very high risks that are neither carried by public money nor by private investors. Supporting seed stage startups fills a crucial gap and is therefore purely philanthropic.
Read more about the Foundation of Founders